Biotricity | 8-K: Current report
Apr 24 05:22
Biotricity | 8-K: Current report
Apr 3 18:12
Biotricity | 8-K: Current report
Mar 27 05:21
Biotricity | S-1: General form for registration of securities under the Securities Act of 1933
Feb 29 00:54
Biotricity | NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB
Feb 15 06:25
Biotricity | 8-K: Current report
Feb 3 06:32
Biotricity | 8-K: Current report
Nov 7, 2023 05:55
Biotricity | 8-K: Current report
Sep 20, 2023 20:15
Biotricity | 8-K: Biotricity Reports Strong Growth for its First Quarter Fiscal Year 2024 and Provides Financial Results and Business Updates
Aug 17, 2023 20:38
Biotricity | 8-K: Current report
Aug 5, 2023 04:15
Biotricity | 8-K: Current report
Jul 21, 2023 05:14
Biotricity | 8-K: Current report
Jul 6, 2023 04:05
Biotricity | 8-K: Current report
May 19, 2023 04:41
Biotricity | 8-K: Current report
Apr 4, 2023 05:16
Biotricity | DEFA14A: Others
Mar 23, 2023 04:08
Biotricity | DEF 14A: Definitive proxy statements
Mar 14, 2023 04:21
Biotricity | PRE 14A: Preliminary proxy statement not related to a contested matter or merger/acquisition
Mar 3, 2023 03:29
Biotricity | 8-K: Current report
Jan 28, 2023 06:06
Biotricity | 8-K: Current report
Jan 21, 2023 06:27
Biotricity | 8-K: Biotricity Reports Financial Results for Fiscal 2023 Second Quarter Revenue totaled $2.4 million, up 14% sequentially quarter-over-quarter
Nov 19, 2022 01:59
No Data
No Data